Total Non-Current Liabilities

$803.29M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$437.25Mperiod endingDec 31, 2025

BCRX FY Total Non-Current Liabilities ($800.00K → $437.25M)

Annual total non-current liabilities

High-resolution chart · PNG

BCRX total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Total Non-Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Non-Current Liabilities (USD)
Dec 31, 2025	437,245,000
Dec 31, 2024	805,970,000
Dec 31, 2023	822,500,000
Dec 31, 2022	739,083,000
Dec 31, 2021	591,419,000
Dec 31, 2020	248,323,000
Dec 31, 2019	44,695,000
Dec 31, 2018	28,129,000
Dec 31, 2017	19,656,000
Dec 31, 2016	33,909,000
Dec 31, 2015	12,378,000
Dec 31, 2014	3,552,000
Dec 31, 2013	34,736,000
Dec 31, 2012	40,669,000
Dec 31, 2011	67,402,000
Dec 31, 2010	16,121,985
Dec 31, 2009	18,671,056
Dec 31, 2008	21,157,445
Dec 31, 2007	49,694,186
Dec 31, 2006	36,595,796
Dec 31, 2005	29,426,214
Dec 31, 2004	300,000
Dec 31, 2003	301,000
Dec 31, 2002	300,000
Dec 31, 2001	300,000
Dec 31, 2000	5,223,531
Dec 31, 1999	300,000
Dec 31, 1998	300,000
Dec 31, 1997	300,000
Dec 31, 1996	300,000
Dec 31, 1995	700,000
Dec 31, 1994	800,000